Literature DB >> 8069647

Physical properties and quantification of the ECT stimulus: I. Basic principles.

H A Sackeim1, J Long, B Luber, J R Moeller, I Prohovnik, D P Devanand, M S Nobler.   

Abstract

The physical properties of the electroconvulsive therapy (ECT) stimulus markedly affect both efficacy and side effects. We review basic principles in characterizing these physical properties and in quantifying the ECT stimulus. The topics discussed include the application of Ohm's law, alternative composite units of ECT dosage (energy and charge), the use of constant-current, constant-voltage, and constant-energy principles in ECT devices, the nature of current shunting in ECT and the determinants of impedance, the relations between impedance and seizure threshold, the seizure-eliciting efficiency of alternative stimulus waveforms and of stimulus parameter configurations, and the role of reactive components (capacitance and inductance) in the ECT circuit. New findings are also presented regarding several of these issues.

Entities:  

Mesh:

Year:  1994        PMID: 8069647

Source DB:  PubMed          Journal:  Convuls Ther        ISSN: 0749-8055


  20 in total

Review 1.  Fundamentals of transcranial electric and magnetic stimulation dose: definition, selection, and reporting practices.

Authors:  Angel V Peterchev; Timothy A Wagner; Pedro C Miranda; Michael A Nitsche; Walter Paulus; Sarah H Lisanby; Alvaro Pascual-Leone; Marom Bikson
Journal:  Brain Stimul       Date:  2011-11-01       Impact factor: 8.955

Review 2.  [Adverse cognitive effects and ECT].

Authors:  Michael Prapotnik; Roger Pycha; Csaba Nemes; Peter König; Armand Hausmann; Andreas Conca
Journal:  Wien Med Wochenschr       Date:  2006-04

Review 3.  Meta-analysis of initial seizure thresholds in electroconvulsive therapy.

Authors:  Jeroen A van Waarde; Bastiaan Verwey; Rose C van der Mast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-21       Impact factor: 5.270

4.  What is the role of brain stimulation therapies in the treatment of depression?

Authors:  Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

5.  Evidence of transcranial direct current stimulation-generated electric fields at subthalamic level in human brain in vivo.

Authors:  Pratik Y Chhatbar; Steven A Kautz; Istvan Takacs; Nathan C Rowland; Gonzalo J Revuelta; Mark S George; Marom Bikson; Wuwei Feng
Journal:  Brain Stimul       Date:  2018-03-13       Impact factor: 8.955

6.  Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy.

Authors:  Angel V Peterchev; Andrew D Krystal; Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2015-04-28       Impact factor: 7.853

7.  A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT).

Authors:  Gregory L Sahlem; William V McCall; E Baron Short; Peter B Rosenquist; James B Fox; Nagy A Youssef; Andrew J Manett; Suzanne E Kerns; Morgan M Dancy; Laryssa McCloud; Mark S George; Harold A Sackeim
Journal:  Brain Stimul       Date:  2020-07-29       Impact factor: 8.955

8.  Fidelity of ECT Devices : An alert to Clinicians.

Authors:  Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2003-10       Impact factor: 1.759

9.  Focal electrically administered therapy: device parameter effects on stimulus perception in humans.

Authors:  Jeffrey J Borckardt; Katherine J Linder; Raffaella Ricci; Xingbao Li; Berry Anderson; Ashley Arana; Ziad Nahas; Vahe Amassian; James Long; Mark S George; Harold A Sackeim
Journal:  J ECT       Date:  2009-06       Impact factor: 3.635

10.  Effect of anatomical variability on electric field characteristics of electroconvulsive therapy and magnetic seizure therapy: a parametric modeling study.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2014-07-17       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.